15
Participants
Start Date
April 17, 2024
Primary Completion Date
August 17, 2024
Study Completion Date
August 17, 2024
Automated insulin delivery system algorithm with a dual-hormone configuration (insulin and glucagon) for glucose control
Participants will wear a CSII system with the CGM device. Insulin will be administered through the AID dHmG system, and microdoses of glucagon (GlucaGen®) will be subcutaneously administered based on automatic recommendations for hypoglycemia mitigation. The subcutaneous administration of reconstituted glucagon will be conducted using a 0.5 mL insulin syringe with needle, allowing for precise doses as small as 0.01mg/0.01 mL.
Automated insulin delivery system with a single-hormone configuration (insulin) with rescue carbohydrate recommendations for glucose control
Participants will wear a CSII system with the CGM device. Insulin will be administered through the AID sHC system, along with automatic rescue carbohydrate recommendations for hypoglycemia mitigation. As per the carbohydrate recommendation, participants will received the suggested amount of carbohydrates using an oral glucose gel containing 15g of carbohydrates per unit.
RECRUITING
Hospital Clínico Universitario de Valencia, Valencia
Hospital Clínico Universitario de Valencia
OTHER
Universitat Politècnica de València
OTHER